Adult progressive intrahepatic cholestasis associated with genetic variations in ATP8B1 and ABCB11

Hepatology Research

Volumn 39, Issue 6, 2009, Pages 625-631

  Hsu, Yao Chun ^a,b   Chen, Huey Ling ^b   Wu, Mu Zon ^b   Liu, Yu Jung ^b   Lee, Po Huang ^b   Sheu, Jin Chuan ^b   Chen, Chien Hung ^b  

^a LOTUNG POH AI HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B11; ADENOSINE TRIPHOSPHATASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLESTYRAMINE; CYTOSINE; GAMMA GLUTAMYLTRANSFERASE; STEROID; TYROSINE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG PULSE THERAPY; ECHOGRAPHY; ENZYME ACTIVITY; EXON; FOLLOW UP; GENETIC VARIABILITY; HEPATOMEGALY; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HYPERBILIRUBINEMIA; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPLENOMEGALY; TREATMENT OUTCOME;

EID: 66449086512     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00499.x     Document Type: Article

References (28)

1. Gopal DV, Rosen HR. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med 2000; 107: 100-2, 5-9, 13-14.
2. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994; 18: 134-41.
3. Carlton VE, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum Mol Genet 1995; 4: 1049-53.
4. Bull LN, van Eijk MJ, Pawlikowska L et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998; 18: 219-24.
5. Strautnieks SS, Kagalwalla AF, Tanner MS et al. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet 1997; 61: 630-3.
6. Strautnieks SS, Bull LN, Knisely AS et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-8.
7. Maggiore G, Bernard O, Riely CA, Hadchouel M, Lemonnier A, Alagille D. Normal serum gamma-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis. J Pediatr 1987; 111: 251-2.
8. Klomp LW, Vargas JC, van Mil SW et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004; 40: 27-38.
9. Summerskill WH, Walshe JM. Benign recurrent intrahepatic "obstructive"jaundice. Lancet 1959; 2: 686-90.
10. Biempica L, Gutstein S, Arias IM. Morphological and biochemical studies of benign recurrent cholestasis. Gastroenterology 1967; 52: 521-35.
11. Mil SW, van der Woerd WL, van der Brugge G et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004; 127: 379-84.
12. Kubitz R, Keitel V, Scheuring S, Kohrer K, Haussinger D. Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J Clin Gastroenterol 2006; 40: 171-5.
13. Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension. World J Surg 1995; 19: 420-2; discussion 3.
14. Chen HL, Liu YJ, Su YN et al. Diagnosis of BSEP/ABCB11 mutations in Asian patients with cholestasis using denaturing high performance liquid chromatography. J Pediatr 2008; 153: 825-32.
15. Pauli-Magnus C, Lang T, Meier Y et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004; 14: 91-102.
16. Keitel V, Vogt C, Haussinger D, Kubitz R. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 2006; 131: 624-9.
17. Lang C, Meier Y, Stieger B et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics 2007; 17: 47-60.
18. Jacquemin E, Setchell KD, O'Connell NC et al. A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/ isomerase deficiency. J Pediatr 1994; 125: 379-84.
19. Alonso EM, Snover DC, Montag A, Freese DK, Whitington PF. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994; 18: 128-33.
20. Bull LN, Carlton VE, Stricker NL et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1]and Byler syndrome): Evidence for heterogeneity. Hepatology 1997; 26: 155-64.
21. Chen HL, Chang PS, Hsu HC et al. FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels. J Pediatr 2002; 140: 119-24.
22. Gerloff T, Stieger B, Hagenbuch B et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273: 10046-50.
23. Jansen PL, Strautnieks SS, Jacquemin E et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999; 117: 1370-9.
24. Chen F, Ananthanarayanan M, Emre S etal. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 2004; 126: 756-64.
25. Paulusma CC, Groen A, Kunne C et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 2006; 44: 195-204.
26. Cai SY, Gautam S, Nguyen T, Soroka CJ, Rahner C, Boyer JL. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. Gastroenterology 2008; DOI: 10.1053/j.gastro.2008.10.025.
27. Nakamuta M, Sakamoto S, Miyata Y, Sato M, Nawata H. Benign recurrent intrahepatic cholestasis: A long-term follow-up. Hepatogastroenterology 1994; 41: 287-9.
28. Ooteghem NA, Klomp LW, van Berge-Henegouwen GP, Houwen RH. Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: Low GGT cholestasis is a clinical continuum. J Hepatol 2002; 36: 439-43.